The Nucleocapsid Protein of Rift Valley Fever Virus Is a Potent Human CD8(+) T Cell Antigen and Elicits Memory Responses

There is no licensed human vaccine currently available for Rift Valley Fever Virus (RVFV), a Category A high priority pathogen and a serious zoonotic threat. While neutralizing antibodies targeting the viral glycoproteins are protective, they appear late in the course of infection, and may not be in...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Weidong, Watts, Douglas M., Costanzo, Margaret C., Tang, Xiaolei, Venegas, Leon A., Jiao, Feng, Sette, Alessandro, Sidney, John, Sewell, Andrew K., Wooldridge, Linda, Makino, Shinji, Morrill, John C., Peters, Clarence J., Kan-Mitchell, June
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601065/
https://www.ncbi.nlm.nih.gov/pubmed/23527138
http://dx.doi.org/10.1371/journal.pone.0059210

Ejemplares similares

Ejemplares similares